Pages that link to "Q48607608"

The following pages link to Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance (Q48607608):

Displaying 33 items.

• Addiction, dopamine, and the molecular mechanisms of memory (Q28142501) (← links)
• The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat (Q28293887) (← links)
• The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats (Q31789217) (← links)
• Adeno-associated virus vectors: activity and applications in the CNS. (Q33958498) (← links)
• PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease (Q34154766) (← links)
• Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398. (Q34746310) (← links)
• L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission (Q35424424) (← links)
• Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs (Q35923169) (← links)
• Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa (Q36085612) (← links)
• Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism (Q36161888) (← links)
• Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilat (Q36791342) (← links)
• Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 (Q37132571) (← links)
• Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism. (Q37629269) (← links)
• Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets. (Q38602173) (← links)
• Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats (Q42439354) (← links)
• NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats (Q43562356) (← links)
• Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. (Q43875632) (← links)
• Topographical Organization of Opioid Peptide Precursor Gene Expression Following Repeated Apomorphine Treatment in the 6-Hydroxydopamine-Lesioned Rat (Q44348262) (← links)
• The dopamine D3 receptor and drug addiction (Q44722668) (← links)
• Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons (Q46636521) (← links)
• Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats (Q48215571) (← links)
• A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study (Q48227459) (← links)
• Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist (Q48363366) (← links)
• Unpredictable rotational responses to L-dopa in the rat model of Parkinson's disease: the role of L-dopa pharmacokinetics and striatal dopamine depletion. (Q48945974) (← links)
• Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine. (Q50794033) (← links)
• The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat (Q56700734) (← links)
• Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease (Q64869820) (← links)
• Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation (Q72452072) (← links)
• Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats (Q73222094) (← links)
• Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment (Q73222097) (← links)
• Restoration and putative protection in Parkinsonism (Q79760124) (← links)
• Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease (Q83257922) (← links)
• Flibanserin attenuates l-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease (Q83315846) (← links)